This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Ready to Break Out

Ariad Pharmaceuticals

One biopharmaceutical player that's quickly moving within range of triggering a major breakout trade is Ariad Pharmaceuticals (ARIA - Get Report), an oncology company that focuses on the discovery, development and commercialization of medicines for cancer patients. This stock has been on fire over the last three months, with shares up a whopping 59%.

If you take a look at the chart for Ariad Pharmaceuticals, you'll notice that this has been trending sideways and consolidating over the last month, with shares moving between $5.92 on the downside and $7.75 on the upside. Shares of ARIA are gapping up here and starting to move within range of triggering a major breakout trade above the upper-end of its recent sideways trading chart pattern.

Must Read: 2 Biotech Stocks Under $10 to Watch

>>2 Biotech Stocks Under $10 to Watch

Traders should now look for long-biased trades in ARIA if it manages to break out above some near-term overhead resistance at $7.75 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 26.20 million shares. If that breakout hits soon, then ARIA will set up to re-fill some of its previous gap down zone from last October that started near $18 a share. If ARIA gets into that gap with strong volume, then this stock could easily tag $10 to $12 a share.

Traders can look to buy ARIA off any weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support levels at $6.32 or at $5.92 a share. One can also buy ARIA off strength once it starts to take out $7.75 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
ARIA $7.17 -0.69%
CNDO $3.69 -2.89%
CSUN $0.26 -5.18%
NWBO $1.52 -0.33%
STXS $1.45 -6.52%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs